To boost or not to boost: Providers tackle the question … Exercise may protect against brain volume loss due to aging, investigators say … FDA delays REGEN-COV approval decision to July … U.S. economic burden of MS is $85 billion; long-term care policy among solutions … Diabetes drug liraglutide improves Parkinson’s mobility in mid-stage trial
Clinical briefs for Friday, April 15
April 15, 2022